sulfobromophthalein has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As patients with type 2 diabetes receiving oral antidiabetic drugs are often concomitantly treated with other drugs, they are of increased risk for drug interactions." | 1.39 | The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members. ( Fromm, MF; Klatt, S; König, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Chen, L | 1 |
| Zhang, H | 1 |
| Huang, S | 1 |
| Xiong, Y | 1 |
| Xia, C | 1 |
| Klatt, S | 1 |
| Fromm, MF | 1 |
| König, J | 1 |
| Serdiuk, VA | 1 |
| Novopashennaia, VV | 1 |
3 other studies available for sulfobromophthalein and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3.
Topics: Diabetes Mellitus, Type 2; Drug Interactions; Glycyrrhizic Acid; HEK293 Cells; Hepatocytes; Humans; | 2018 |
The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members.
Topics: Administration, Oral; Atorvastatin; Biological Transport; Diabetes Mellitus, Type 2; Drug Interactio | 2013 |
[Liver function in diabetics with secondary sulfanilamide resistance (based on the data from dynamic hepatobiliary scintigraphy)].
Topics: Biliary Tract; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Resistanc | 1991 |